By Mrinalika Roy and Sriparna Roy June 17 (Reuters) - U.S. supplies of progesterone are coming under strain, with patients, ...

Here’s what researchers found.

Clinical guidance still calls for a nuanced approach in postmenopausal women ...

Researchers found that women taking menopausal hormone therapy had a 69% lower risk of low bone mineral density than those ...

This article was reviewed by Julia Switzer, MD, FACOG. If you’re entering perimenopause or menopause, you’ve probably heard about hormone replacement therapy (HRT) — and you might be wondering about ...

Women on menopausal hormonal therapy face a decreased risk of low bone mineral density compared to those not using it, ...

See more of our coverage in your search results. Add The New York Post on Google Menopause can usher in a host of disruptive symptoms like hot flashes, night sweats and sleep problems. Hormone therapy ...

The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminizing hormone therapy. This is demonstrated by an ...

GnRH agonists may be a better adjunctive option than progesterone for transgender patients on estrogen-based therapy.